Borderline Resectable Pancreatic Cancer: What Have We Learned and Where Do We Go From Here?

By Katz Matthew  

Annals of Surgical Oncology, Vol. 18, Iss. 3, 2011-03 ,pp. : 608-610

Springer Publishing Company

Access to resources Recommend Favorite

Thyroid cancer pooled analysis from 14 case–control studies: what have we learned?

By Preston‐Martin Susan  

Cancer Causes and Control, Vol. 14, Iss. 8, 2003-01 ,pp. : 787-789

Springer Publishing Company

Access to resources Recommend Favorite

Tomato-based food products for prostate cancer prevention: what have we learned?

By Tan Hsueh-Li  

Cancer and Metastasis Reviews, Vol. 29, Iss. 3, 2010-09 ,pp. : 553-568

Springer Publishing Company

Access to resources Recommend Favorite

Radiation and Thyroid Cancer: What More Can be Learned?

By Boice John D.  

Acta Oncologica, Vol. 37, Iss. 4, 1998-10 ,pp. : 321-324

Informa Healthcare

Access to resources Recommend Favorite

Clinical Trials with Retrovirus Mediated Gene Therapy – what Have we Learned?

By Rainov Nikolai G.   Ren Huan  

Journal of Neuro-Oncology, Vol. 65, Iss. 3, 2003-12 ,pp. : 227-236

Springer Publishing Company

Access to resources Recommend Favorite